TABLE 2.
Antifungal susceptibility of G. argillacea isolates to amphotericin B, itraconazole, voriconazole, posaconazole, and caspofungin obtained using the NCCLS/CLSI broth microdilution methoda
| Isolate | Source | MIC (mg/liter) for: |
||||
|---|---|---|---|---|---|---|
| Amphotericin | Itraconazole | Voriconazole | Caspofungin | Posaconazole | ||
| NCPF 2801 | Sputum, CF patient, UK, 1991 | 1 | 0.5 | 16 | 2 | ND |
| NCPF 7594 | Isolated from blood culture, patient with peritonitis, UK, 2002 | 2 | 0.5 | 16 | 0.5 | ND |
| NCPF 7596 | Isolated from peritoneal dialysis fluid of same patient as NCPF 7594 | 2 | 0.5 | 16 | 0.25 | ND |
| CF isolate 1 | Leeds Teaching Hospitals Trust, CF subject 4 | 0.5 | 0.5 | >16 | 0.25 | 0.5 |
| CF isolate 2 | Leeds Teaching Hospitals Trust, CF subject 3 | 2 | 0.5 | >16 | 0.5 | 0.5 |
a
UK, United Kingdom; ND, not determined.